RTKN2 anticorps (AA 1-572)

N° du produit ABIN7869483

L’anticorps anti-RTKN2 Polyclonal Lapin est utilisé pour la détection de RTKN2 dans des échantillons de Humain, Souris et Rat. Il a été validé pour ELISA, WB et FACS.

Aperçu rapide pour RTKN2 anticorps (AA 1-572) (ABIN7869483)

Antigène: RTKN2 (Rhotekin 2 (RTKN2))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RTKN2 est non-conjugé

Application: ELISA, Western Blotting (WB), Flow Cytometry (FACS)

Détail du produit anti-RTKN2 anticorps

Épitope: AA 1-572

Fonction: RTKN2 Antibody / Rhotekin 2

Purification: Immunogen affinity purified

Immunogène: E.coli-derived human RTKN2 recombinant protein (Position: M1-D572) was used as the immunogen for the RTKN2 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the RTKN2 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the RTKN2 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur RTKN2

Antigène: RTKN2 (Rhotekin 2 (RTKN2))

Autre désignation: RTKN2

Sujet: RTKN2 antibody detects Rhotekin 2, a Rho GTPase effector protein that regulates cytoskeletal dynamics, apoptosis, and immune cell signaling. The UniProt recommended name is Rhotekin 2 (RTKN2). This protein acts as a scaffold for RhoA-mediated signaling pathways that control actin organization, transcriptional activity, and cell survival.

Functionally, RTKN2 antibody identifies a 646-amino-acid cytoplasmic protein containing a Rho-binding domain (RBD) and ankyrin repeats that mediate protein-protein interactions. RTKN2 binds active GTP-bound RhoA to stabilize cytoskeletal structures and prevent apoptotic signaling. It also influences NF-kappaB activation and transcriptional regulation of immune and inflammatory genes. In T lymphocytes, RTKN2 promotes cell survival and proliferation by integrating RhoA and anti-apoptotic signaling pathways.

The RTKN2 gene is located on chromosome 10q21.1 and is highly expressed in lymphoid tissues, testis, and brain. Expression increases during T-cell activation and stress responses, indicating roles in immune signaling and cytoskeletal adaptation. RTKN2 contributes to both structural stability and signaling plasticity within dynamic cellular environments.

Pathologically, RTKN2 has been implicated in cancer and autoimmune disease. Overexpression enhances survival and proliferation of cancer cells through activation of NF-kappaB and suppression of apoptosis, whereas reduced RTKN2 expression may impair lymphocyte function and stress resistance. Research using RTKN2 antibody supports studies in Rho GTPase signaling, cytoskeletal dynamics, and immune cell regulation.

RTKN2 antibody is validated for western blotting, immunofluorescence, and immunohistochemistry to detect Rho effector proteins. NSJ Bioreagents provides RTKN2 antibody reagents optimized for research in signal transduction, apoptosis regulation, and cytoskeletal remodeling.

Structurally, Rhotekin 2 consists of a central RhoA-binding domain, ankyrin repeats, and multiple phosphorylation sites that control its localization and interaction with downstream effectors. Its structure enables binding to GTP-bound RhoA and integration with cell survival pathways. This antibody facilitates analysis of RTKN2's role in Rho-dependent signaling and immune cell function.

UniProt: Q8IZC4